Y-mAbs Therapeutics, Inc. Comprehensive Income
Y-mAbs Therapeutics, Inc. reported Comprehensive Income of -$5.25 million for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-08.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2025-08-08
- Y-mAbs Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-06-30 was -$5.25M.
- Y-mAbs Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-03-31 was -$6.06M.
- Y-mAbs Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2024-12-31 was -$4.49M.
- Y-mAbs Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2024-09-30 was -$8.08M.
- Y-mAbs Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$27.85M.
- Y-mAbs Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$22.31M.
- Y-mAbs Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$95.61M.
- Y-mAbs Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2021 was -$53.38M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2025-06-30 | -$5.25M 10-Q · filed 2025-08-08 | -$11.31M 10-Q · filed 2025-08-08 | -$15.80M derived: sum of 3 quarters · filed 2025-08-08 | -$23.88M derived: sum of 4 quarters · filed 2025-08-08 |
| 2025-03-31 | -$6.06M 10-Q · filed 2025-05-13 | -$10.55M derived: sum of 2 quarters · filed 2025-05-13 | -$18.63M derived: sum of 3 quarters · filed 2025-05-13 | -$27.68M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-12-31 | -$4.49M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | -$12.57M derived: sum of 2 quarters · filed 2025-03-04 | -$21.62M derived: sum of 3 quarters · filed 2025-08-08 | -$27.85M 10-K · filed 2025-03-04 |
| 2024-09-30 | -$8.08M 10-Q · filed 2024-11-08 | -$17.13M derived: sum of 2 quarters · filed 2025-08-08 | -$23.36M 10-Q · filed 2024-11-08 | -$25.75M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-06-30 | -$9.05M 10-Q · filed 2025-08-08 | -$15.28M 10-Q · filed 2025-08-08 | -$17.67M derived: sum of 3 quarters · filed 2025-08-08 | -$24.61M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | -$6.23M 10-Q · filed 2025-05-13 | -$8.62M derived: sum of 2 quarters · filed 2025-05-13 | -$15.56M derived: sum of 3 quarters · filed 2025-05-13 | -$21.84M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | -$2.39M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | -$9.33M derived: sum of 2 quarters · filed 2025-03-04 | -$15.61M derived: sum of 3 quarters · filed 2025-03-04 | -$22.31M 10-K · filed 2025-03-04 |
| 2023-09-30 | -$6.94M 10-Q · filed 2024-11-08 | -$13.22M derived: sum of 2 quarters · filed 2024-11-08 | -$19.92M 10-Q · filed 2024-11-08 | -$22.14M derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | -$6.28M 10-Q · filed 2024-08-12 | -$12.98M 10-Q · filed 2024-08-12 | -$15.19M derived: sum of 3 quarters · filed 2024-08-12 | -$41.12M derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | -$6.70M 10-Q · filed 2024-05-07 | -$8.91M derived: sum of 2 quarters · filed 2024-05-07 | -$34.84M derived: sum of 3 quarters · filed 2024-05-07 | -$74.55M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | -$2.21M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$28.14M derived: sum of 2 quarters · filed 2024-02-29 | -$67.85M derived: sum of 3 quarters · filed 2024-02-29 | -$95.61M 10-K · filed 2024-02-29 |
| 2022-09-30 | -$25.93M 10-Q · filed 2023-11-13 | -$65.64M derived: sum of 2 quarters · filed 2023-11-13 | -$93.39M 10-Q · filed 2023-11-13 | -$129.14M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | -$39.71M 10-Q · filed 2023-08-10 | -$67.47M 10-Q · filed 2023-08-10 | -$103.21M derived: sum of 3 quarters · filed 2023-08-10 | -$131.83M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$27.76M 10-Q · filed 2023-05-08 | -$63.50M derived: sum of 2 quarters · filed 2023-05-08 | -$92.12M derived: sum of 3 quarters · filed 2023-05-08 | -$114.98M derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | -$35.75M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$64.37M derived: sum of 2 quarters · filed 2023-03-30 | -$87.23M derived: sum of 3 quarters · filed 2023-03-30 | -$53.38M 10-K · filed 2023-03-30 |
| 2021-09-30 | -$28.62M 10-Q · filed 2022-11-07 | -$51.48M derived: sum of 2 quarters · filed 2022-11-07 | -$17.63M 10-Q · filed 2022-11-07 | -$38.06M derived: sum of 4 quarters · filed 2022-11-07 |
| 2021-06-30 | -$22.86M 10-Q · filed 2022-08-08 | $10.99M 10-Q · filed 2022-08-08 | -$9.44M derived: sum of 3 quarters · filed 2022-08-08 | -$42.29M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $33.85M 10-Q · filed 2022-05-09 | $13.42M derived: sum of 2 quarters · filed 2022-05-09 | -$19.43M derived: sum of 3 quarters · filed 2022-05-09 | -$59.91M derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | -$20.43M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$53.27M derived: sum of 2 quarters · filed 2022-03-01 | -$93.76M derived: sum of 3 quarters · filed 2022-03-01 | -$119.91M 10-K · filed 2022-03-01 |
| 2020-09-30 | -$32.84M 10-Q · filed 2021-11-04 | -$73.33M derived: sum of 2 quarters · filed 2021-11-04 | -$99.48M 10-Q · filed 2021-11-04 | -$122.70M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | -$40.48M 10-Q · filed 2021-08-09 | -$66.64M 10-Q · filed 2021-08-09 | -$89.86M derived: sum of 3 quarters · filed 2022-03-01 | -$113.64M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | -$26.15M 10-Q · filed 2021-05-06 | -$49.37M derived: sum of 2 quarters · filed 2022-03-01 | -$73.16M derived: sum of 3 quarters · filed 2022-03-01 | -$91.26M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | -$23.22M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$47.01M derived: sum of 2 quarters · filed 2022-03-01 | -$65.11M derived: sum of 3 quarters · filed 2022-03-01 | -$80.98M 10-K · filed 2022-03-01 |
| 2019-09-30 | -$23.79M 10-Q · filed 2020-11-05 | -$41.89M derived: sum of 2 quarters · filed 2020-11-05 | -$57.77M 10-Q · filed 2020-11-05 | -$71.77M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | -$18.10M 10-Q · filed 2020-08-06 | -$33.98M 10-Q · filed 2020-08-06 | -$47.99M derived: sum of 3 quarters · filed 2020-08-06 | -$59.37M derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | -$15.88M 10-Q · filed 2020-05-07 | -$29.88M derived: sum of 2 quarters · filed 2020-05-07 | -$41.27M derived: sum of 3 quarters · filed 2020-05-07 | -$51.50M derived: sum of 4 quarters · filed 2020-05-07 |
| 2018-12-31 | -$14.01M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | -$25.39M derived: sum of 2 quarters · filed 2020-03-12 | -$35.62M derived: sum of 3 quarters · filed 2020-03-12 | -$43.10M 10-K · filed 2020-03-12 |
| 2018-09-30 | -$11.39M 10-Q · filed 2019-11-13 | -$21.61M derived: sum of 2 quarters · filed 2019-11-13 | -$29.09M 10-Q · filed 2019-11-13 | -$38.42M derived: sum of 4 quarters · filed 2019-11-13 |
| 2018-06-30 | -$10.23M 10-Q · filed 2019-08-14 | -$17.71M 10-Q · filed 2019-08-14 | -$27.04M derived: sum of 3 quarters · filed 2019-08-14 | -$30.92M derived: sum of 4 quarters · filed 2019-08-14 |
| 2018-03-31 | -$7.48M 10-Q · filed 2019-05-10 | -$16.81M derived: sum of 2 quarters · filed 2019-05-10 | -$20.69M derived: sum of 3 quarters · filed 2019-05-10 | |
| 2017-12-31 | -$9.33M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | -$13.21M derived: sum of 2 quarters · filed 2019-03-22 | -$19.36M 10-K · filed 2019-03-22 | |
| 2017-09-30 | -$3.88M 10-Q · filed 2018-11-13 | -$10.03M 10-Q · filed 2018-11-13 |